Your institution may have access to this item. Find your institution then sign in to continue.
Title
NEW PRODUCTS.
Abstract
Introduces several obstetrics and gynecological products. Decision of the U.S. Food and Drug Administration to approve Sanctura for the treatment of overactive bladder; Compact Ductless Fume Systems for soaking ultrasound probes from PCI Medical Inc.; Release of Raniclor, the first chewable cephalosporin for treating urinary tract infections from Ranbaxy Pharmaceuticals Inc.